BD Showcases Expanded Portfolio to Support Enterprise Medication Management at the ASHP 2015 Midyear Meeting

Visit the "BD Leadership Theater" to hear how health systems improve and advance quality and safety across the continuum of care

FRANKLIN LAKES, N.J., Dec. 2, 2015 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company and CareFusion, a BD company, will present its combined, strengthened solutions together as one company, at the 50th Annual American Society of Health-system Pharmacists (ASHP) Midyear Clinical Meeting being held Dec. 6-10 in New Orleans.

BD will display a comprehensive portfolio of medication management solutions at the Ernest N. Morial Convention Center, booth #2339. From IV preparation in the pharmacy to administration at the bedside, medication dispensing and automation in expanding care settings, and enterprise monitoring to supporting care for population health management, booth attendees will receive a hands-on demonstration of the broader and deeper suite of solutions designed to help improve the safety and cost of healthcare.

"The combined representation of BD and CareFusion during this year's ASHP meeting exemplifies a significant journey in the transformation of how we provide more advanced solutions for the many challenges concerning medication management," said Tom Polen, executive vice president at BD and president of BD's Medical Segment. "BD is now even better positioned to address the challenges in medication management with our extensive and strengthened solutions. Our expanded portfolio being displayed at ASHP will provide a firsthand experience of the value our connected offerings bring to patients and health care workers."

BD is also sponsoring the Intelligent Pharmacy Pavilion (IPP) located at the center of the exhibit hall booth #1738. The IPP exhibit will feature the first-ever BD Leadership Theater, a venue where conference attendees can attend live panel discussions composed of clinicians across the continuum of care as they discuss new technologies used in today's hospitals and ambulatory care pharmacies. Throughout the week, the BD Leadership Theater will also host discussions led by current BD technology users as they share best practices around today's top priorities concerning hospital pharmacists, including:

  • Achieving transformational change in the pharmacy
  • Adoption of enterprise inventory and OR medication management
  • Advancing infusion therapy through smart pump-EMR interoperability
  • Redefining the IV replenishment process from the pharmacy to the patient's bedside
  • Hazardous drug risk reduction and drug vial management
  • Advancements in technologies to improve medication management in non-acute settings

Receive an in-depth view of the medical technologies and unique capabilities designed to help solve challenges and simplify the process of managing medications from real users by visiting the BD Leadership Theater during general conference hours. For more information, or to register for any of the BD-sponsored activities at ASHP, please visit:

About BD 
BD is a leading medical technology company that partners with customers and stakeholders to address many of the world's most pressing and evolving health needs. Our innovative solutions are focused on improving medication management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; improving drug delivery; aiding anesthesiology and respiratory care; advancing cellular research and applications; enhancing the diagnosis of infectious diseases and cancers; and supporting the management of diabetes. We are more than 45,000 associates in 50 countries who strive to fulfill our purpose of "Helping all people live healthy lives" by advancing the quality, accessibility, safety and affordability of healthcare around the world. In 2015, BD welcomed CareFusion and its products into the BD family of solutions. For more information on BD, please visit

Matt Coppola
BD Public Relations


To view the original version on PR Newswire, visit:

SOURCE BD (Becton, Dickinson and Company)